MOUNTAIN VIEW, Calif., July 28, 2023 (GLOBE NEWSWIRE) — Respective results from the REVEALPLAQUE, DECODE, and SMART-CT clinical studies demonstrate the accuracy, utility, and efficiency of HeartFlow’s portfolio of coronary computed tomography angiography (CCTA)-based precision coronary care technologies. Study results were presented at the Society of Cardiovascular Computed Tomography (SCCT) Conference in […]
Other News
Ionis expands eplontersen agreement with AstraZeneca to include exclusive rights in Latin America
CARLSBAD, Calif., July 28, 2023 /PRNewswire/ — Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced it has expanded its existing collaboration with AstraZeneca to include exclusive rights for AstraZeneca to commercialize eplontersen in Latin America. Ionis previously granted AstraZeneca exclusive rights to commercialize eplontersen in all other countries outside the U.S. Ionis and AstraZeneca will continue to jointly […]
Argon Medical Devices Recognized as 2023 Top Workplace in Manufacturing
PLANO, Texas, July 28, 2023 /PRNewswire/ — Argon Medical Devices, a leading manufacturer of medical devices for interventional procedures, announces recognition as a 2023 Top Workplace in the USA Manufacturing sector. Recipients of the Top Workplaces awards are selected based on feedback from a research-backed employee engagement survey initiated by technology company, Energage. Top […]
RapidAI Announces $75 Million Growth Investment Led by Vista Credit Partners
SAN MATEO, Calif.–(BUSINESS WIRE)–RapidAI, a global leader in developing Artificial Intelligence (AI) and technology workflow solutions to combat life-threatening neurovascular, cardiac and vascular diseases, today announced $75 million in Series C funding led by Vista Credit Partners, a subsidiary of Vista Equity Partners and strategic financing partner focused on the enterprise software, data […]
MyoVista wavECG goes into clinical use at the Naya Imaging Center in Denmark
Southlake, Texas, July 27, 2023 (GLOBE NEWSWIRE) — Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”), an artificial intelligence (AI)-based medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease, today announces that its MyoVista® wavECGTM has been selected for commercial use in […]
TransMedics Appoints Anil Ranganath as Senior Vice President, General Counsel and Corporate Secretary
ANDOVER, Mass., July 26, 2023 /PRNewswire/ — TransMedics Group, Inc. (“TransMedics”) (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, announced today the appointment of Anil Ranganath as Senior Vice President, General Counsel and Corporate Secretary. “We are excited to welcome Anil […]
ConcertAI’s TeraRecon Partners with ClariPi to Integrate AI Solutions for Comprehensive Medical Imaging on Eureka Clinical AI Platform
CAMBRIDGE, Mass., July 27, 2023 /PRNewswire/ — Advanced visualization and AI leader TeraRecon, a ConcertAI company, announced today a strategic partnership with ClariPi, an innovative medical imaging AI company, to integrate ClariPi’s solutions into its Eureka platform. With this partnership, TeraRecon continues to expand its offerings to enhance clinical workflows, delivering comprehensive […]
BOSTON SCIENTIFIC ANNOUNCES RESULTS FOR SECOND QUARTER 2023
MARLBOROUGH, Mass., July 27, 2023 /PRNewswire/ — Boston Scientific Corporation (NYSE: BSX) generated net sales of $3.599 billion during the second quarter of 2023, growing 11.0 percent on a reported basis, 12.0 percent on an operational1 basis and 11.6 percent on an organic2 basis, all compared to the prior year period. The company reported GAAP net income […]
FDA Grants Clearance for UltraSight’s AI-Powered Cardiac Ultrasound Technology
TEL AVIV, Israel, July 27, 2023 /PRNewswire/ — Today, UltraSight, a digital health pioneer transforming cardiac imaging through the power of artificial intelligence, announced that it has been granted FDA clearance for its AI-powered ultrasound guidance technology. The UltraSight real-time AI guidance software can assist medical professionals without sonography experience in acquiring cardiac […]
EDWARDS LIFESCIENCES REPORTS SECOND QUARTER RESULTS
IRVINE, Calif., July 26, 2023 /PRNewswire/ — Edwards Lifesciences (NYSE: EW) today reported financial results for the quarter ended June 30, 2023. Highlights and Outlook Q2 sales grew 11 percent to $1.53 billion; constant currency1 sales grew 12 percent All product groups achieved double digit constant currency sales growth in Q2 Q2 TAVR sales grew 9 percent; […]



